Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

Lead

Icahn School of Medicine at Mount Sinai

With

• Herbert Irving Comprehensive Cancer Center
• Weill Medical College of Cornell University
• NYU Langone Health